GILEAD SCIENCES INC (GILD) Stock Analyst Ratings
USA - NASDAQ:GILD - US3755581036 - Common Stock
120.94 USD
+0.2 (+0.17%)
120.94 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 81% to GILD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 128.04. This target is 5.87% above the current price.
GILD was analyzed by 36 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about GILD.
In the previous month the buy percentage consensus was at a similar level.
GILD was analyzed by 36 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-23 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-08 | Citigroup | Maintains | Buy -> Buy |
| 2025-09-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-08 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-08-08 | Truist Securities | Upgrade | Hold -> Buy |
| 2025-07-25 | Needham | Upgrade | Hold -> Buy |
| 2025-05-21 | Needham | Reiterate | Hold -> Hold |
| 2025-04-25 | Needham | Reiterate | Hold -> Hold |
| 2025-04-25 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-25 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-03-27 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-03-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-05 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-04 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-02-18 | Deutsche Bank | Upgrade | Hold -> Buy |
| 2025-02-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-02-12 | Needham | Reiterate | Hold -> Hold |
| 2025-02-12 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-02-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-12 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-02-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-02-12 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-02-03 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2025-01-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-10 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2024-12-11 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-12-11 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-12-10 | Oppenheimer | Reiterate | Outperform -> Outperform |
GILEAD SCIENCES INC / GILD FAQ
What is the average price target for GILEAD SCIENCES INC (GILD) stock?
36 analysts have analysed GILD and the average price target is 128.04 USD. This implies a price increase of 5.87% is expected in the next year compared to the current price of 120.94.
What is the consensus rating for GILEAD SCIENCES INC (GILD) stock?
The consensus rating for GILEAD SCIENCES INC (GILD) is 81.1111 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for GILD stock?
The number of analysts covering GILEAD SCIENCES INC (GILD) is 36.